Top Markets
Coin of the day
Dr. Agarwal's Health Care Limited Dr. Agarwal's Health Care Limited

Dr. Agarwal's Health Care Limited

AGARWALEYE
Peringkat dalam Saham #7063
Dr. Agarwal's Health Care Limited manages a chain of eye hospitals both within... Dr. Agarwal's Health Care Limited manages a chain of eye hospitals both within India and abroad. The company delivers a comprehensive range of ophthalmic services, including advanced surgical solutions for cataracts like small incision, phacoemulsification, robotic, and glued intraocular lens procedures. It also offers refractive surgeries designed to correct visual errors, thereby lessening or removing the necessity for glasses and contact lenses. Additional surgical specialties include treatments for retinal conditions, corneal transplantation, pinhole pupilloplasty, oculoplasty, and operations for glaucoma and pterygium. Beyond surgical interventions, the company provides professional medical consultations, in-depth diagnostic services for various eye disorders, and non-surgical therapies such as retinal laser treatment and dry eye management. Furthermore, Dr. Agarwal's Health Care Limited sells optical goods, including spectacles, lenses, contact lenses, and frames, as well as a variety of pharmaceutical products for eye care. The company was founded in 2010 and is based in Chennai, India.
Harga Saham
$5.48
Kapitalisasi Pasar
$1.74B
Perubahan (1 hari)
-0.10%
Perubahan (1 tahun)
9.22%
Negara
IN
Perdagangan Dr. Agarwal's Health Care Limited (AGARWALEYE)

Kategori

Laba untuk Dr. Agarwal's Health Care Limited (AGARWALEYE)
Laba pada 2026 TTM: 0
Menurut laporan keuangan terbaru dari Dr. Agarwal's Health Care Limited, laba saat ini perusahaan adalah 0. Pada tahun 2026, perusahaan memperoleh laba sebesar 0, sama dengan laba tahun 2026 sebesar 0. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Dr. Agarwal's Health Care Limited dari 2026 hingga 2026
Laba pada akhir setiap tahun
Tahun Laba Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Laba untuk perusahaan serupa atau pesaing